Clinical trial No longer in our active list Interventional Ages 18 to 45 Women only

Treatment for women with a specific type of PCOS

Official title: Treatment of Menstrual Cycle Alterations in Women with PCOS of Phenotype D Using Dietary Supplementation That Combines Diosgenin, Vitamin D and Alpha-lactalbumin

Run by Lo.Li.Pharma s.r.l · NCT06639698 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing a dietary supplement to see if it can help women with a specific type of PCOS get their menstrual cycles back on track and improve their ovarian health.

More PCOS (Polycystic Ovary Syndrome) trials

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexWomen only
Enrollment20 (estimated)
SponsorLo.Li.Pharma s.r.l
Industry-sponsored
Locations1 site (Rome, ITA)
Trial IDNCT06639698 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women diagnosed with PCOS of phenotype D who meet the inclusion criteria.

Probably not a fit

Patients with other phenotypes of PCOS, hormonal treatments, or significant metabolic alterations may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial focuses on female patients diagnosed with PCOS of phenotype D, characterized by menstrual cycle alterations and normal androgen levels. Participants will receive a dietary supplement containing Dioscorea extract, vitamin D, and alpha-lactalbumin for six months. The primary goal is to restore regular menstrual cycles and improve the ultrasound appearance of the ovaries, addressing the limitations of current treatments for this phenotype. The study aims to evaluate the efficacy of this natural approach in managing symptoms of PCOS phenotype D.

Why it matters

Potential benefit: If successful, this treatment could provide a new, effective option for managing symptoms of PCOS phenotype D without the side effects of traditional hormonal therapies.

How similar studies have gone: While there is limited data on the specific use of Diosgenin for this phenotype, other studies exploring natural supplements for PCOS have shown promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of PCOS of phenotype D, according to the Rotterdam Criteria and the EGOI-PCOS Criteria

Exclusion Criteria:

* Diagnosis of PCOS of phenotype A, B or C, according to the Rotterdam Criteria and the EGOI-PCOS Criteria
* Hormonal treatments;
* Treatments with inositol or other insulin sensitizers (such as metformin);
* Insulin resistance or pre-diabetes condition
* BMI \> 30
* Endocrinological alterations
* Chronic pharmacological therapies
* Major pathological conditions (e.g. tumors or autoimmune diseases)

Where it's running

  • Alma Res Fertility Center
    Rome, Ita, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.